TU Dresden


The global market for stem cell products, including pluripotent and reprogramed stem cells, cell culture tools and consumables, disease model systems, and cellular therapeutics, is set to rise to over 100 billion by 2020.

The Center for Regenerative Therapies (CRTD) contributes to this market through its world-leading research in the area of regenerative biology and medicine. Our mission is to translate basic scientific discoveries and know-how into clinically relevant applications and marketable products through alliances with the biotechnology, pharmaceutical and diagnostics industries.

CRTD brings innovative technologies and established expertise to its partnerships with industry, particularly in the areas of neurodegenerative diseases, retina degeneration, type I diabetes and pancreatic islet regeneration, and stem cell niches. In its technology transfer endeavour, CRTD works intensively with partners at the Biotech Campus Dresden, including the Biotechnology Center (BIOTEC), B CUBE and the University Hospital Carl Gustav Carus Dresden.